CD34 modulates the trafficking behavior of hematopoietic cells in vivo

Stem Cells and Development

Volumn 16, Issue 2, 2007, Pages 297-304

  Lange, Claudia ^a   Li, Zhixiong ^b   Fang, Lubin ^a   Baum, Christopher ^b   Fehse, Boris ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; ENHANCED GREEN FLUORESCENT PROTEIN; RETROVIRUS VECTOR;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CELL DIFFERENTIATION; CELL MIGRATION; CONTROL GROUP; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; IN VIVO STUDY; ISOGRAFT; MALE; MOUSE; NONHUMAN; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; THYMOCYTE;

ANIMALS; ANTIGENS, CD34; BONE MARROW TRANSPLANTATION; CELL ADHESION; CELL DIFFERENTIATION; CELL MOVEMENT; FEMALE; HEMATOPOIETIC STEM CELLS; MALE; MICE; MICE, INBRED C57BL; RETROVIRIDAE; TRANSDUCTION, GENETIC; TRANSGENES;

ANIMALIA; MURINAE;

EID: 34249016696     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2006.0056     Document Type: Article

References (37)

1. Krause DS, MJ Fackler, CI Civin and WS May. (1996). CD34: Structure, biology and clinical utility. Blood 87:1-13.
2. Lanza F, L Healy and DR Sutherland. (2001). Structural and functional features of the CD34 antigen: an update. J Biol Regul Homeost Agents 15:1-13.
3. Berenson RJ, RG Andrews, WI Bensinger, D Kalamasz, G Knitter, CD Buckner and ID Bernstein. (1988). Antigen CD34+ marrow cells engraft lethally irradiated baboons. J Clin Invest 81:951-955.
4. Krause DS, T Ito, MJ Fackler, OM Smith, MI Collector, SJ Sharkis and WS May. (1994). Characterization of murine CD34, a marker for hematopoietic progenitor and stem cells. Blood 84:691-701.
5. + marrow cells in patients with breast cancer or neuroblastoma. Blood 77:1717-1722.
6. + blood cells. Blood 87:4903-4909.
7. Osawa M, K Hanada, H Hamada and H Nakauchi. (1996). Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science 273: 242-245.
8. + stem cell line. J Hematother Stem Cell Res 8:335-342.
9. Goodell MA, M Rosenzweig, H Kim, DF Marks, M DeMaria, G Paradis, SA Grupp, CA Sieff, RC Mulligan and RP Johnson. (1997). Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nature Med 3:1337-1345.
10. -: Does it really matter? Blood 94:2545-2547.
11. - cell preparations. Exp Hematol 29:910-921.
12. Drew E, CS Huettner, DG Tenen and KM McNagny. (2005). CD34 expression by mast cells: of mice and men. Blood 106:1885-1887.
13. Gordon MY, SB Marley, RJ Davidson, FH Grand, JL Lewis, DX Nguyen, S Lloyd and JM Goldman. (2000). Contact-mediated inhibition of human haematopoietic progenitor cell proliferation may be conferred by stem cell antigen. CD34. Hematol J 1:77-86.
14. Healy L, G May, K Gale, F Grosveld, M Greaves and T Enver. (1995). The stem cell antigen CD34 functions as a regulator of hemopoietic cell adhesion. Proc Natl Acad Sci USA 92:12240-12244.
15. Gangenahalli GU, VK Singh, YK Verma, P Gupta, RK Sharma, R Chandra and PM Luthra. (2006). Hematopoietic stem cell antigen CD34: role in adhesion or homing. Stem Cell Develop 15:305-313.
16. Sato T, JH Laver and M Ogawa. (1999). Reversible expression of CD34 by murine hematopoietic stem cells. Blood 94:2548-2554.
17. Ogawa M. (2002). Changing phenotypes of hematopoietic stem cells. Exp Hematol 30:3-6.
18. Fackler MJ, DS Krause, OM Smith, CI Civin and WS May. (1995). Full-length but not truncated CD34 inhibits hematopoietic cell differentiation of M1 cells. Blood 85:3040-3047.
19. Cheng J, S Baumhueter, G Cacalano, K Carver-Moore, H Thibodeaux, R Thomas, HE Broxmeyer, S Cooper, N Hague, M Moore and LA Lasky. (1996). Hematopoietic defects in mice lacking the sialomucin CD34. Blood 87:479-490.
20. Broxmeyer HE, S Cooper, G Hangoc and CH Kim. (2005). Stromal cell-derived factor-1/CXCL12 selectively counteracts inhibitory effects of myelosuppressive chemokines on hematopoietic progenitor cell proliferation in vitro. Stem Cells Dev 14:199-203.
21. Suda J, T Sudo, M Ito, N Ohno, Y Yamaguchi and T Suda. (1992). Two types of murine CD34 mRNA generated by alternative splicing. Blood 79: 2288-2295.
22. Simmons DL, AB Satterthwaite, DG Tenen and B Seed. (1992). Molecular cloning of a cDNA encoding CD34, a sialomucin of human hematopoietic stem cells. J Immunol 148:267-271.
23. Hu MC and SL Chien. (1998). The cytoplasmic domain of stem cell antigen CD34 is essential for cytoadhesion signaling but not sufficient for proliferation signaling. Blood 91:1152-1162.
24. Fehse B, A Richters, K Putimtseva-Scharf, H Klump, Z Li, W Ostertag, AR Zander and C Baum. (2000). CD34 splice variant: an attractive marker for selection of gene-modified cells. Mol Ther 1:448-456.
25. Li Z, B Fehse, B Schiedlmeier, J Düllmann, O Frank, AR Zander, W Ostertag and C Baum. (2002). Persisting mullilineage transgene expression in the clonal progeny of a hematopoietic stem cell. Leukemia 16:1655-1663.
26. Hildinger M, KL Abel, W Ostertag and C Baum. (1999). Design of 5′ untranslated sequences in retroviral vectors developed for medical use. J Virol 73:4083-4089.
27. Wahlers A, M Schwieger, Z Li, D Meier-Tackmann, C Lindemann, HG Eckert, D von Laer and C Baum. (2001). Influence of multiplicity of infection and protein stability on retroviral vector-mediated gene expression in hematopoishy; etic cells. Gene Ther 8:477-486.
28. Li Z, M Schwieger, C Lange, J Kraunus, H Sun, E van den Akker, U Modlich, E Serinsöz, E Will, D von Laer, C Stocking, B Fehse, B Schiedlmeier and C Baum. (2003). Predictable and efficient retroviral gene transfer into murine bone marrow repopulating cells using a defined vector dose. Exp Hematol 31:1206-1214.
29. Moritz T, P Dutt, X Xiao, D Carstanjen, T Vik, H Hanenberg and DA Williams. (1996). Fibronectin improves transduction of reconstituting hematopoietic stem cells by retroviral vectors: evidence of direct viral binding to chymotryptic carboxy-terminal fragments. Blood 88:855-862.
30. Kühlcke K, B Fehse, A Schilz, S Loges, C Lindemann, F Ayuk, F Lehmann, N Stute, AA Fauser, AR Zander and HG Eckert. (2002). Highly efficient retroviral gene transfer based on centrifugation-mediated vector pre-loading of tissue culture vessels. Mol Ther 5:473-478.
31. Kustikova OS, A Wahlers, K Kühlcke, B Stähle, AR Zander, C Baum and B Fehse. (2003). Dose finding with retroviral vectors: Correlation of retroviral vector copy numbers in single cells with gene transfer efficiency in a cell population. Blood 102:3934-3937.
32. Fehse B, OS Kustikova, M Bubenheim and C Baum (2004). Pois(s)on ... It's a question of dose. Gene Ther 11:879-881.
33. Modlich U, OS Kustikova, M Schmidt, C Rudolph, J Meyer, Z Li, K Kamino, N von Neuhoff, B Schlegelberger, K Kuehlcke, KD Bunting, S Schmidt, A Deichmann, C von Kalle, B Fehse and C Baum. (2005). Leukemias following retroviral transfer of multidrug resistance 1 (MDR1) are driven by combinatorial insertional mutagenesis. Blood 105:4235-4246.
34. Fehse B, OS Kustikova, Z Li, A Wahlers, W Bonn, WR Beyer, D Chalmers, P Tiberghien, K Kühlcke, AR Zander and C Baum. (2002). A novel "sort-suicide" fusion gene vector for T cell manipulation. Gene Ther 9:1633-1638.
35. Kustikova O, B Fehse, U Modlich, M Yang, J Düllmann, K Kamino, N von Neuhoff, B Schlegelberger, Z Li and C Baum (2005) Clonal dominance of hematopoietic stem cells triggered by retroviral gene marking. Science 308: 1171-1174.
36. Ott MG, M Schmidt, K Schwarzwaelder, S Stein, U Siler, U Koehl, H Glimm, K Kühlcke, A Schilz, H Kunkel, S Naundorf, A Brinkmann, A Deichmann, M Fischer, C Ball, I Pilz, C Dunbar Y, Du, NA Jenkins, NG Copeland, U Luthi, M Hassan, AJ Thrasher, D Hoelzer, C von Kalle, R Seger and M Grez. (2006). Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nature Med 12:401-409.
37. + cells from bone marrow to peripheral blood is selective in steady-state hematopoiesis and during G-CSF administration. J Hematother 6:563-573.